Literature DB >> 8610605

Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia.

H H Schmidt1, S Hill, E V Makariou, I M Feuerstein, K A Dugi, J M Hoeg.   

Abstract

The high concentrations of low-density lipoprotein cholesterol in plasma lead to accelerated atherosclerosis in patients homozygous for familial hypercholesterolemia (FH). We addressed the hypothesis that lipid deposition in the arterial vasculature and in nonvascular tissues in these patients correlates with both the duration and severity of their hypercholesterolemia. The severity of calcific atherosclerosis was defined by calcification scores and a calcified volume determined by electron beam tomography. The extent of tendinous xanthomatosis was quantitated by computed tomography. A cholesterol-year score was calculated based on the age and the yearly mean serum cholesterol concentration of each patient. Seventeen patients homozygous for FH were followed up. The average total cholesterol concentration in the study group was 780 +/- 231 mg/dl (20.2 mmol/L), and the cholesterol-year scores ranged from 2,172 mg-year/dl (56 mmol-year/L) to 32,260 mg-year/dl (834 mmol-year/L). Achilles tendon width (r=0.86) and cross-sectional area (r=0.81; both p <0.001) were best correlated with the cholesterol-year score. In addition, the coronary (r=0.61; p<0.05), ostial (r=0.45; p<0.05), and total (r= 0.77; p<0.001) calcification atherosclerosis scores all were best correlated with the cholesterol-year score. Calcific atherosclerosis was not observed in these patients until the cholesterol-year score exceeded 10,000 mg-year/dl (260 mmol-year/L). These findings establish a direct association of cholesterol-year with extravascular lipid deposition in tissues of patients with FH. The cholesterol-year score may be useful in defining the risk of atherosclerosis in patients with more common forms of hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610605     DOI: 10.1016/s0002-9149(97)89309-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  Detection of subclinical atherosclerosis by electron beam tomography in females with heterozygous familial hypercholesterolaemia.

Authors:  R D Santos; R S Meneghelo; A P M Chacra; T L R Martinez; J A Ramires; J A M Carvalho
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

3.  Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score.

Authors:  Silvia Morbelli; Francesco Fiz; Arnoldo Piccardo; Lorena Picori; Michela Massollo; Emanuela Pestarino; Cecilia Marini; Manlio Cabria; Alessia Democrito; Giuseppe Cittadini; Giampiero Villavecchia; Paolo Bruzzi; Abass Alavi; Gianmario Sambuceti
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-08       Impact factor: 2.357

Review 4.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

5.  Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively.

Authors:  Michael Ibrahim; Ismail El-Hamamsy; Mahmoud Barbir; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2011-09-01       Impact factor: 4.132

6.  Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.

Authors:  Matthias Gautschi; Mladen Pavlovic; Jean-Marc Nuoffer
Journal:  JIMD Rep       Date:  2011-09-06

Review 7.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

8.  What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?

Authors:  Frederick J Raal; Evan A Stein
Journal:  J Lipid Res       Date:  2014-03-27       Impact factor: 5.922

Review 9.  Novel Therapies for Familial Hypercholesterolemia.

Authors:  Justin Parizo; Ashish Sarraju; Joshua W Knowles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11

Review 10.  Lipids in liver transplant recipients.

Authors:  Anna Hüsing; Iyad Kabar; Hartmut H Schmidt
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.